Serving people
Our commercial activities
“We have an ambition to protect 1.5 million travelers in 2023”
Dipal Patel, Chief Commercial Officer
Our ambitions for a changing world
At Valneva, we are committed to prioritizing the development and distribution of new vaccines for infectious diseases with significant unmet medical need.
Our Marketing & Distribution Structure
Valneva has a specialist commercial infrastructure for the distribution of its travelers’ vaccines and third-party vaccines in key markets.
Our commercial business 2022
Our Manufacturing Network
Our manufacturing base provides a long-term and sustainable industrial network to supply commercial and clinical products. We currently operate three manufacturing sites augmented by contract manufacturing partners.